All In Biotech

Free tool

FAERS Monitor: Neupro

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021829 or its brand name (Neupro, Rotigotine). Reports on generic versions are filed under their own applications.

Reports

14,738

Serious

9,295

63% of reports

Hospitalization

4,277

Death reported

2,175

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • product adhesion issue1,963
  • drug ineffective1,171
  • fall1,013
  • death984
  • off label use922
  • parkinson^s disease800
  • hallucination771
  • dyskinesia698
  • tremor655
  • nausea555
  • dizziness523
  • somnolence477
  • fatigue469
  • gait disturbance466
  • insomnia466

Reports by year received

View as table
YearReports
2007128
2008603
2009126
2010131
2011129
2012170
2013260
2014302
2015471
2016820
2017917
2018866
20191,295
20201,207
20211,579
20221,461
20231,098
20241,164
20251,075
2026936

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,039,421 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (400). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
product adhesion issueSignal1,96382.979.4150,293
dyskinesiaSignal69824.923.215,759
hallucinationSignal77114.713.89,795
tremorSignal6555.75.22,512
fallSignal1,0134.44.12,648
gait disturbanceSignal4663.53.2827
somnolenceSignal4773.43.1806
insomniaSignal4662.52.3422
death9841.61.5249
off label use9221.51.4161
dizziness5231.51.488
drug ineffective1,1711.31.271
nausea5551.00.90
fatigue4690.90.811
parkinson^s disease8000.00.01,140,665

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.